The Impact of Obesity on Dysmenorrhea and Lower Urinary Tract Symptoms in Adenomyosis Patients

Authors

  • Asih Anggraeni Department of Obstetrics and Gynecology Faculty of Medicine Universitas Sebelas Maret Surakarta
  • Yudhistya Ngudi Insan Ksyatria Department of Obstetrics and Gynecology Faculty of Medicine Universitas Sebelas Maret Surakarta https://orcid.org/0009-0006-8743-0039
  • Ikhwan Department of Obstetrics and Gynecology Faculty of Medicine Universitas Sebelas Maret Surakarta https://orcid.org/0009-0007-1655-2714

DOI:

https://doi.org/10.21776/ub.jkb.2024.033.02.6

Keywords:

Adenomyosis, dysmenorrhea, lower urinary tract symptoms, obesity

Abstract

Obesity poses a substantial health challenge globally, affecting various aspects of reproductive health, including adenomyosis. Adenomyosis, characterized by the presence of endometrial tissue within the myometrium, commonly affects women during their reproductive years, leading to symptoms such as dysmenorrhea and lower urinary tract symptoms (LUTS). This study aimed to investigate the influence of obesity on dysmenorrhea and LUTS severity in adenomyosis patients, considering demographic factors such as age and educational levels as potential moderators. Forty-four adenomyosis patients participated in a cross-sectional study at Dr. Moewardi General Hospital in Surakarta City of Indonesia, between April and September 2023. Diagnosis was confirmed using 2D Transvaginal Ultrasound (2D-TVUS). Obesity was defined using Body Mass Index (BMI) categories, and dysmenorrhea and LUTS were assessed using the Numerical Rating Scale (NRS) and modified International Prostate Symptom Score (IPSS) questionnaire, respectively. Statistical analyses included Pearson correlation. Results indicated a significant positive correlation between obesity and dysmenorrhea (rho = 0.256, P = 0.049) and LUTS (rho = 0.292, P = 0.029). Age and educational level did not significantly moderate these relationships, emphasizing the independent influence of obesity on symptom severity. In conclusion, obesity significantly impacts the severity of dysmenorrhea and LUTS in adenomyosis patients, highlighting the need for tailored management strategies that address both hormonal and inflammatory pathways.

Downloads

Download data is not yet available.

References

Ates S, Aydın S, and Ozcan P. Cardiometabolic Profiles in Women with Adenomyosis. Journal of Obstetrics and Gynaecology. 2022; 42(7): 3080-3085.

Rossi M, Vannuccini S, Capezzuoli T, et al. Mechanisms and Pathogenesis of Adenomyosis. Current Obstetrics and Gynecology Reports. 2022; 11: 95-102.

Li T, Xu XX, Dai Y, Zhang JJ, Lang JH, and Leng JH. Menorrhagia and Uterine Volume Associated with Lower Urinary Tract Symptoms in Patients with Adenomyosis. Chinese Medical Journal. 2017; 130(13): 1552-1556.

Boutari C and Mantzoros CS. A 2022 Update on the Epidemiology of Obesity and a Call to Action: As Its Twin Covid-19 Pandemic Appears to be Receding, the Obesity and Dysmetabolism Pandemic Continues to Rage On. Metabolism. 2022; 133: 1-7.

Decter D, Arbib N, Markovitz H, Seidman DS, and Eisenberg VH. Sonographic Signs of Adenomyosis in Women with Endometriosis are Associated with Infertility. Journal of Clinical Medicine. 2021; 10(11): 1-10.

World Health Organization. Obesity and Overweight. (Online) March 1, 2024. Available from: https://www.who.int/news-room/fact-sheets /detail/obesity-andoverweight#:~:text=For% 20adults%2C%20WHO%20defines%20overweight,than%20or%20equal%20to%2030 [accessed on 10 March 2024].

Mizuta R, Maeda N, Tashiro T, et al. Quality of Life By Dysmenorrhea Severity in Young and Adult Japanese Females: A Web-Based Cross-Sectional Study. PLoS One. 2023; 18(3): 1-16.

Gewanter RM, Sandhu JS, Tin AL, et al. Assessment of Patients with Prostate Cancer and Their Understanding of the International Prostate Symptom Score Questionnaire. Advances in Radiation Oncology. 2023; 8(4): 1-6.

Tangel SJC, Monoarfa A, and Monoarfa RA. Validasi International Prostate Symptom Score Versi Bahasa Indonesia pada Penderita Lower Urinary Tract Symptoms di Poliklinik Urologi RSUP Prof. Dr. R. D. Kandou Manado. Jurnal Biomedik: JBM. 2019; 11(2): 92-96.

Vannuccini S, Tosti C, Carmona F, et al. Pathogenesis of Adenomyosis: An Update on Molecular Mechanisms. Reproductive BioMedicine Online. 2017; 35(5): 592-601.

Yu O, Schulze-Rath R, Grafton J, Hansen K, Scholes D, and Reed SD. Adenomyosis Incidence, Prevalence and Treatment: United States Population-Based Study 2006-2015. American Journal of Obstetrics & Gynecology. 2020; 223(1): 94.e1-94.e10.

Jiang C and Cheng Z. Update of Recent Studies of Adenomyosis-Associated Dysmenorrhea. Gynecology and Minimally Invasive Therapy. 2016; 5(4): 137-140.

Aydin GA and Yavuz A. Adenomyosis and Urinary System Symptoms. European Journal of Obstetrics, Gynecology, and Reproductive Biology. 2018; 224: 74-76.

Shaffer RK, Dobberfuhl AD, Fast AM, Vu KN, Ghanouni P, and Chen B. Lower Urinary Tract and Pelvic Floor Symptoms and their Correlation with Fibroid Characteristics. Obstetrics & Gynecology. 2018; 131(1): 151S.

Lee U, Kerkhof MH, van Leijsen SA, and Heesakkers JP. Obesity and Pelvic Organ Prolapse. Current Opinion in Urology. 2017; 27(5): 428-434.

Ding S, Madu CO, Lu Y. The Impact of Hormonal Imbalances Associated with Obesity on the Incidence of Endometrial Cancer in Postmenopausal Women. Journal of Cancer. 2020; 11(18): 5456-5465.

Ellulu MS, Patimah I, Khaza'ai H, Rahmat A, and Abed Y. Obesity and Inflammation: The Linking Mechanism and the Complications. Archives of Medical Science. 2017; 13(4): 851-863.

Downloads

Published

2024-08-30

Issue

Section

Original Article

Similar Articles

1-10 of 94

You may also start an advanced similarity search for this article.